Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on December 30, 2005
About 2.2 million adolescents ages 12to 17 (9 percent) experienced at least one major depressive episode in thepast year. These adolescents were more than twice as likely to have usedillicit drugs in the past month than their peers who had not experienced amajor depressive episode (21.2 percent compared with 9… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (28 September) launched a clinical guideline on the treatment and management of depression in children and young people. The guideline recommends that - - Children and young people with moderate to severe depression should be offered, as a first-line treatment, a specific psychological therapy (such as cognitive behavioural therapy, interpersonal therapy or family therapy of at least 3 months’ duration)… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
Aetna CEO John Rowe on Wednesday is expected to announce a plan under which the insurer will increase payments to physicians who participate in a depression management program focusing on screening and follow-up consultations, the New York Times reports… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
FDA on Thursday issued a public health advisory warning pregnant women and physicians about an increased risk of fetal heart defects from taking GlaxoSmithKline’s antidepressant Paxil — known generically as paroxetine — during the first three months of pregnancy, the … click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
Not only does depression put a physical and emotional strain on the individuals, but it is also associated with enormous costs both to themselves as well as to society at large, a recent study suggests. The results from the study concluded that the total cost of depression in 28 European countries was estimated at €118 billion in 2004 ($139 billion USD)… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
The beneficial effects of a widely used class of antidepressants might be the result of increased nerve-fiber growth in key parts of the brain, according to a Johns Hopkins study being published in the January 2006 issue of the Journal of Neurochemistry. The study on rats, led by Vassilis E… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for desvenlafaxine extended release (DVS-233) for the treatment of major depressive disorder (MDD). Desvenlafaxine extended release represents Wyeth’s ongoing commitment to research and development of new antidepressant therapies… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Mental Health have today (28 September) launched a clinical guideline on the treatment and management of depression in children and young people. The guideline recommends that - - Children and young people with moderate to severe depression should be offered, as a first-line treatment, a specific psychological therapy (such as cognitive behavioural therapy, interpersonal therapy or family therapy of at least 3 months’ duration)… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
Aetna CEO John Rowe on Wednesday is expected to announce a plan under which the insurer will increase payments to physicians who participate in a depression management program focusing on screening and follow-up consultations, the New York Times reports… click link for more info.
Popularity: unranked [?]
By Depressed Jane on December 29, 2005
FDA on Thursday issued a public health advisory warning pregnant women and physicians about an increased risk of fetal heart defects from taking GlaxoSmithKline’s antidepressant Paxil — known generically as paroxetine — during the first three months of pregnancy, the … click link for more info.
Popularity: unranked [?]
